Key player · Company profile

Gilead Sciences, Inc.

Named as a key player in 66 of our reports, across 33 regions and countries.

Fastest-growing markets they play in

2023–2033 CAGR · estimates

  1. 1Cell Based Immunotherapy (India) 26%
  2. 2HIV Drugs (India) 8.8%

Where they show up

  • Pharmaceuticals66

Geographies

Gilead Sciences, Inc.'s markets

Markets where Gilead Sciences, Inc. is a key player, with the world market size
MarketCategoryWorld 2023CAGR
HIV Drugs Pharmaceuticals$30 Bn5.8%
Cell Based Immunotherapy Pharmaceuticals$16.6 Bn23%

Companies they compete with most

Named as key players in the same markets as Gilead Sciences, Inc. (number of shared markets).

AbbVie Inc.2 shared markets Bristol-Myers Squibb2 shared markets Dendreon Pharmaceuticals LLC1 shared market F. Hoffmann-La Roche Ltd1 shared market GlaxoSmithKline plc1 shared market Johnson & Johnson1 shared market Merck & Co., Inc.1 shared market Novartis AG1 shared market

Recent reports naming Gilead Sciences, Inc.

Search all reports for Gilead Sciences, Inc. All companies